TMCnet News
Global Large Volume Wearable Injectors Market Research Report 2014 with a 10 Year Outlook(M2 PressWIRE Via Acquire Media NewsEdge) Dublin - Research and Markets (http://www.researchandmarkets.com/research/pvp8dh/large_volume) has announced the addition of the "Large Volume Wearable Injectors - 2nd Edition" report to their offering. The Large Volume Wearable Injectors' market report provides a comprehensive analysis of the current state of the market and the likely future evolution over the next ten years. Starting with the basic introduction to these injectors, the report lays emphasis on the current unmet needs of the market. As all the large volume wearable injectors are currently only available for investigational use, the investment being done in this area is geared towards tapping the significant future potential of this market. In fact, one of the primary objectives of this report is to estimate the size of this future promise offered by such injectors. A large number of biologics are currently under development and a majority of these molecules are highly viscous and require to be delivered in volumes of greater than 1 ml. It is widely anticipated that devices which will allow self-administration of these molecules will be readily adopted by all stakeholders in the industry. For the purposes of our analysis, we followed a top-down approach to estimate the size of this market. This development is being led jointly by established firms such as Becton Dickinson, West Pharmaceuticals and emerging players such as Unilife, SteadyMed Therapeutics, Ratio Drug Delivery, Sensile Medical, Enable Injections and scPharmaceuticals. It is widely anticipated that, once ready, such devices which will allow self-administration of high viscosity, large volume biologics and be readily adopted in the industry. Key Highlights: - In total, over 15 large volume wearable drug delivery devices (including variants) currently under development have been identified during our research. - Approximately 53% of these devices operate electronically. Other modes of operation include mechanical, hydrogel and hydraulic. Many of these injectors have additional features such as an audio / visual panel making their usage very easy for the end users. - The range of volume these devices can cater to is as high as 30 ml. The first commercial launch is anticipated to take place in 2015/2016. In our research, we have profiled five drugs which are currently undergoing trials for delivery via large volume injectors. - Pharma companies also have many undisclosed research programs.We have identified about 30 biologics which are likely to be immediate targets for preparation of subcutaneous formulation and delivery via large volume wearable injectors. In addition to these highly likely candidates, there are more than 100 other drug-disease combinations which are expected to draw interest in the short-mid term. - The manufacturer's landscape is still evolving. In addition the established firms such as Becton Dickinson and West Pharma, many start-ups including Unilife, Sensile Medical, SteadyMed Therapeutics and Enable Injections are heading towards the pole position - The growth in biologics will be one of the key drivers for the emergence of large volume wearable injectors. Around 50% of the top 100 selling drugs are expected to be biologics by 2016; biologics are estimated to contribute 27% of the total drugs market by 2020. - Other key reasons for the growth of bolus injectors include their potential to act as life cycle management tool, increasing trend towards drug self-administration and the overall drive towards cheaper healthcare costs. Key Topics Covered: 1. Preface 2. Executive Summary 3. Introduction 4. Overview And Market Background 5. Target Drugs For Large Volume Wearable Injectors 6. Case Studies 7. Product Profiles 8. Market Size And Forecast 9. SWOT Analysis 10. Company Profiles 11. Interview Transcripts 12. Conclusion 13. Appendix 1: Tabulated Data 14. Appendix 2: List Of Companies And Organizations For more information visit http://www.researchandmarkets.com/research/pvp8dh/large_volume CONTACT: Research and Markets, Laura Wood, Senior Manager. [email protected] Fax from USA: 646-607-1907 Fax from rest of the world: +353-1-481-1716 Sector: Medical Devices (http://www.researchandmarkets.com/categories.asp?cat_id=61&campaign_id=pvp8dh) . (c) 2014 M2 COMMUNICATIONS |